612
Participants
Start Date
August 27, 2015
Primary Completion Date
September 22, 2017
Study Completion Date
October 13, 2017
Azilsartan medoxomil
Azilsartan medoxomil tablets
Valsartan
Valsartan 80 mg capsules
Azilsartan medoxomil Placebo
Azilsartan medoxomil placebo-matching tablets
Valsartan Placebo
Valsartan placebo-matching capsules
The 4th Hospital of Hebei Medical University, Shijiazhuang
Beijing Chao Yang Hospital, Beijing
Beijing Anzhen Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Tong Ren Hospital, Capital Medical University, Beijing
People's Hospital of Liaoning Province, Shenyang
China-Japan Union Hospital of Jilin University, Changchun
Shanghai Changzheng Hospital, Shanghai
Shanghai East Hospital, Shanghai
Cardiology/Zhong Da Hospital, Southeast University, Nanjing
Nanjing Medical University Affiliated 2nd Hospital, Nanjing
Affiliated Hospital of Jiangsu University, Zhenjiang
The Affiliated Hospital of Xuzhou Medical College, Xuzhou
Tianjin People's Hospital, Tianjin
Tianjin Third Central Hospital, Tianjin
TEDA International Cardiovascular Hospital, Tianjin
The First Affiliated Hospital of NanChang University, Nanchang
Fujian Medical University Union Hospital, Fuzhou
Fujian Provincial Hospital, Fuzhou
The First Affiliated Hospital of Fujian Medical University, Fuzhou
Hunan Province People's Hospital, Changsha
The Third Xiangya Hospital of Central South University, Changsha
Zhuzhou Central Hospital, Fuzhou
Guangdong General Hospital, Guangzhou
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning
Affiliated Hospital of Hainan Medical University., Haikou
First Affiliated Hospital of Xian Jiaotong University, Xi’an
Hebei Cangzhou Central Hospital, Cangzhou
Cardiology/The Second Hospital of Shanxi Medical University, Taiyuan
Lead Sponsor
Takeda
INDUSTRY